BioMarin Pharmaceutical Inc. annual free cash flow for fiscal 2025 was $717 million, an increase of 50.8% from $475 million in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $717M | $475M | $52M | $44M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Free Cash Flow | $200M | $57M | $335M | $168M | $158M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More BMRN metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS
All BMRN financial statements → Interactive BMRN charts →
About TickerBase · Data methodology & sources